Evidence map›Paper›PMID 42641887›Full record

ArticleThe Journal of biological chemistry2026

Protein M of NADC30-like PRRSV induces MARCH6-mediated K33-linked polyubiquitination of SLA-DRA.

Ruochen Hu, Sujing Mou, Chenfei Yu, Jinyao Li, Wenli Shi, Yining Zhang, Saba Nasir, Ruhai Guo, Junda Li, Xinxin Qiu and 2 more

Abstract read
In one paragraph

Article in The Journal of biological chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ruochen HuCollege of Veterinary Medicine, Northwest A&F University, Yangling, China.
Sujing MouCollege of Veterinary Medicine, Northwest A&F University, Yangling, China.
Chenfei YuCollege of Veterinary Medicine, Northwest A&F University, Yangling, China.
Jinyao LiCollege of Veterinary Medicine, Northwest A&F University, Yangling, China.
Wenli ShiCollege of Veterinary Medicine, Northwest A&F University, Yangling, China.
Yining ZhangCollege of Veterinary Medicine, Northwest A&F University, Yangling, China.
Saba NasirCollege of Veterinary Medicine, Northwest A&F University, Yangling, China.
Ruhai GuoCollege of Veterinary Medicine, Northwest A&F University, Yangling, China.
Junda LiCollege of Veterinary Medicine, Northwest A&F University, Yangling, China.
Xinxin QiuDepartment of Animal Engineering/Shaanxi Engineering Research Center of the Prevention and Control for Animal Disease, Shaanxi Vocational and Technical University of Agriculture and Forestry, Yangling, Shaanxi Province, China.
Shuqi XiaoState Key Laboratory for Animal Disease Control and Prevention, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, College of Veterinary Medicine, Lanzhou University, Lanzhou, Gansu, China. Electronic address: xiaoshuqi@caas.cn.
Xinglong WangCollege of Veterinary Medicine, Northwest A&F University, Yangling, China. Electronic address: wxlong@nwsuaf.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

NADC30-like porcine reproductive and respiratory syndrome virus (PRRSV) has replaced the high-pathogenicity PRRSV (HP-PRRSV) as the predominant circulating strain in China. Unlike HP-PRRSV, NADC30-like PRRSV exhibits increased genetic diversity and enhanced persistence for persistent infection, along with altered host immune responses, which collectively complicate disease control. In this study, we found that infection with the NADC30-like representative strain XM2020 induced a weaker antibody response than infection with the HP-PRRSV strain HuB2, and that SLA-DRA expression was downregulated. In vitro analyses further demonstrated that this suppression of SLA-DR in peripheral blood mononuclear cells is independently of viral replication. Mechanistically, XM2020-M binds to SLA-DRA and recruits the E3 ubiquitin ligase MARCH6, promoting K33-linked polyubiquitination and proteasomal degradation of SLA-DRA, a function not observed for HuB2-M. In addition, XM2020-M stabilizes MARCH6 by inhibiting its degradation, thereby enhancing its ubiquitin ligase activity. Further mapping identified residue 93 of XM2020-M as a critical determinant of this process. Collectively, these findings reveal a novel immune evasion mechanism by which XM2020-M impairs antigen presentation by targeting the degradation of SLA-DRA, which may contribute to altered adaptive immune responses and viral persistence associated with NADC30-like strains.

Indexed as

antigen presentationE3 ubiquitin ligaseimmune evasionMHC moleculesNADC30-like PRRSV

Identifiers

PMID42641887
PMCPMC13628661

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.